Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer

ABSTRACT: During this open label study patients will receive IMM-101 in conjunction with a recognised standard of care for metastatic or unresectable cancer for the patient’s specific tumour type. The primary objective of the study is to provide safety data for IMM-101 in combination with a number of selected standard of care regimens.

DISEASE(S): Neoplasm,Neoplasm Metastasis,Sarcoma,Melanoma,Metastatic Cancer,Metastatic Cancer Or Unresectable Cancer

PROVIDER: 2233312 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR